Meeting
2021 ASCO Annual Meeting
Phase II trial of stereotactic ablative radiation (SAbR) for oligoprogressive kidney cancer.
Authors
Raquibul Hannan
University of Texas Southwestern Medical Center, Dallas, TX
Raquibul Hannan , Michael Christensen , Aurelie Garant , Hans J. Hammers , Waddah Arafat , Kevin Dale Courtney , Isaac Alex Bowman , Suzanne Cole , David Sher , Chul Ahn , Robert D. Timmerman , James Brugarolas
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Genitourinary Cancer—Kidney and Bladder
Track
Genitourinary Cancer—Kidney and Bladder
Sub Track
Kidney Cancer
Clinical Trial Registration Number
NCT03696277
Citation
J Clin Oncol 39, 2021 (suppl 15; abstr 4564)
DOI
10.1200/JCO.2021.39.15_suppl.4564
Abstract #
4564
Poster Bd #
Online Only
Abstract Disclosures
Similar Posters
Poster
2021 Genitourinary Cancers Symposium
Phase II trial of stereotactic ablative radiation (SAbR) for oligometastatic kidney cancer.
First Author: Raquibul Hannan
Poster
2023 ASCO Annual Meeting
NRG-GU012: Randomized phase II stereotactic ablative radiation therapy (SABR) for patients with metastatic unresected renal cell carcinoma (RCC) receiving immunotherapy (SAMURAI).
First Author: William A. Hall
Poster
2023 ASCO Genitourinary Cancers Symposium
Phase II trial of cytoreductive stereotactic hypofractionated radiotherapy with combination ipilimumab/nivolumab for metastatic kidney cancer (CYTOSHRINK).
First Author: Aly-Khan A. Lalani
Poster
2023 ASCO Genitourinary Cancers Symposium
Two-fraction stereotactic MRI-guided ablative radiotherapy with simultaneous boost to dominant intraprostatic lesion: Results from the 2SMART phase 2 trial.
First Author: Wee Loon Ong